Post-approval studies (Phase 4)Looking for participantsNCT07152340
What this trial is testing
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Who this might be right for
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital 64